DPY30 and Hyperglycemia: Deletion of Dpy30 from maturing beta cells using Ins1Cre caused reduction of H3K4 methylation in islets by 5 weeks of age, leading to hyperglycaemia, impaired glucose tolerance and reduced serum insulin levels (ESM Fig. 1).